Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer - Concepedia

Concepedia

Publication | Open Access

Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer

DOI Full Paper Access

96

Citations

22

References

2013

Year

Cátia Moutinho, Anna Martínez‐Cardús, Cristina Santos, Valentín Navarro-Perez, Eva Martinez‐Balibrea, Eva Musulén, F. Javier Carmona, Andrea Sartore‐Bianchi, Andrea Cassingena, Salvatore Siena,

JNCI Journal of the National Cancer Institute

Abstract

These results provide a basis for future clinical studies to validate SRBC hypermethylation as a predictive marker for oxaliplatin resistance in colorectal cancer.

References

	Year	Citations
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein, Annals of Oncology Esmo Consensus GuidelinesPersonalized ApproachGastrointestinal OncologyColorectal SurgeryMedicine	2012	1.5K
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors Manel Esteller JNCI Journal of the National Cancer Institute	2000	1.2K
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study Mauro Moroni, Silvio Veronese, Silvia Benvenuti, The Lancet Oncology Cancer EpidemiologyMedicinePathologyColorectal CancerCancer Genomics	2005	948
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer Rosalyn A. Juergens, John Wrangle, Frank P. Vendetti, Cancer Discovery	2011	668
Amplification of the <i>MET</i> Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer Alberto Bardelli, Simona Corso, Andrea Bertotti, Cancer Discovery EngineeringPathologyCancer BiologyTumor BiologyCancer Cell Biology	2013	654
Genome-Wide Dna Methylation Profiling Using Infinium <sup>®</sup> Assay Marina Bibikova, Jennie Le, Bret Barnes, Epigenomics GeneticsDna MethylationDna AnalysisMolecular BiologyGenomics	2009	603
Cellular and molecular pharmacology of oxaliplatin. Éric Raymond, Sandrine Faivre, Stephen G. Chaney, PubMed Molecular PharmacologyChromatinTumor BiologyOncologyAdduct Formation	2002	467
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis Manel Esteller Human Molecular Genetics ChromatinTumor BiologySomatic VariantDna Methylation PatternsEpigenetic Change	2001	441
A DNA methylation fingerprint of 1628 human samples Agustín F. Fernández, Yassen Assenov, José I. Martı́n-Subero, Genome Research Dna Methylation FingerprintsChromatinSystems BiologyDna Methylation FingerprintDna Methylation Patterns	2011	411
Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis Verónica Dávalos, Cátia Moutinho, Alberto Villanueva, Oncogene	2011	348

Page 1